{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T13:49:29Z","timestamp":1783604969316,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,10,11]],"date-time":"2022-10-11T00:00:00Z","timestamp":1665446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,11]],"date-time":"2022-10-11T00:00:00Z","timestamp":1665446400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s10620-022-07714-2","type":"journal-article","created":{"date-parts":[[2022,10,11]],"date-time":"2022-10-11T16:04:16Z","timestamp":1665504256000},"page":"414-422","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Trends in Biochemical Parameters, Healthcare Resource and Medication Use in the 5 Years Preceding IBD Diagnosis: A Health Maintenance Organization Cohort Study"],"prefix":"10.1007","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9252-9208","authenticated-orcid":false,"given":"Nathaniel A.","family":"Cohen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efrat","family":"Kliper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noa","family":"Zamstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomer","family":"Ziv-Baran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matti","family":"Waterman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Hodik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Ben","family":"Tov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Revital","family":"Kariv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,11]]},"reference":[{"key":"7714_CR1","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1002\/ibd.21506","volume":"17","author":"B Pariente","year":"2011","unstructured":"Pariente B, Cosnes J, Danese S et al. Development of the Crohn\u2019s disease digestive damage score, the L\u00e9mann score. Inflamm Bowel Dis. 2011;17:1415\u20131422. https:\/\/doi.org\/10.1002\/ibd.21506.","journal-title":"Inflamm Bowel Dis."},{"key":"7714_CR2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.crohns.2007.06.005","volume":"1","author":"S Ghosh","year":"2007","unstructured":"Ghosh S, Mitchell R. Impact of inflammatory bowel disease on quality of life: results of the European Federation of Crohn\u2019s and Ulcerative Colitis Associations (EFCCA) patient survey. J Crohn\u2019s Colitis. 2007;1:10\u201320. https:\/\/doi.org\/10.1016\/j.crohns.2007.06.005.","journal-title":"J Crohn\u2019s Colitis."},{"key":"7714_CR3","doi-asserted-by":"publisher","first-page":"A511","DOI":"10.1016\/j.jval.2016.09.956","volume":"19","author":"A Katz Avitan","year":"2016","unstructured":"Katz Avitan A, Schwartz D, Greenberg D et al. The impact of inflammatory bowel disease on work productivity: comparison of a real-world sample of patients with Crohn\u2019s disease and ulcerative colitis. Value Heal. 2016;19:A511. https:\/\/doi.org\/10.1016\/j.jval.2016.09.956.","journal-title":"Value Heal."},{"key":"7714_CR4","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.cgh.2019.07.022","volume":"18","author":"GR Lichtenstein","year":"2020","unstructured":"Lichtenstein GR, Shahabi A, Seabury SA et al. Lifetime economic burden of Crohn\u2019s disease and ulcerative colitis by age at diagnosis. Clin Gastroenterol Hepatol. 2020;18:889-897.e10. https:\/\/doi.org\/10.1016\/j.cgh.2019.07.022.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"7714_CR5","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1093\/ecco-jcc\/jjy113","volume":"13","author":"C Maaser","year":"2019","unstructured":"Maaser C, Sturm A, Vavricka SR et al. ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications. J Crohn\u2019s Colitis. 2019;13:144\u2013164. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjy113.","journal-title":"J Crohn\u2019s Colitis."},{"key":"7714_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2006.03.003","author":"T Burgmann","year":"2006","unstructured":"Burgmann T, Clara I, Graff L et al. The manitoba inflammatory bowel disease cohort study: prolonged symptoms before diagnosis-how much is irritable bowel syndrome? Clin Gastroenterol Hepatol. 2006. https:\/\/doi.org\/10.1016\/j.cgh.2006.03.003.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"7714_CR7","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/j.1365-2036.2005.02380.x","volume":"21","author":"A Sainsbury","year":"2005","unstructured":"Sainsbury A, Heatley RV. Review article: Psychosocial factors in the quality of life of patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2005;21:499\u2013508. https:\/\/doi.org\/10.1111\/j.1365-2036.2005.02380.x.","journal-title":"Aliment Pharmacol Ther."},{"key":"7714_CR8","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1016\/S0016-5085(88)80072-6","volume":"95","author":"ME Kanof","year":"1988","unstructured":"Kanof ME, Lake AM, Bayless TM. Decreased height velocity in children and adolescents before the diagnosis of Crohn\u2019s disease. Gastroenterology. 1988;95:1523\u20131527. https:\/\/doi.org\/10.1016\/S0016-5085(88)80072-6.","journal-title":"Gastroenterology."},{"key":"7714_CR9","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1136\/adc.88.11.995","volume":"88","author":"A Sawczenko","year":"2003","unstructured":"Sawczenko A, Sandhu BK. Presenting features of inflammatory bowel disease in Great Britain and Ireland. Arch Dis Child. 2003;88:995\u20131000. https:\/\/doi.org\/10.1136\/adc.88.11.995.","journal-title":"Arch Dis Child."},{"key":"7714_CR10","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1093\/ecco-jcc\/jjz057","volume":"13","author":"R Frei","year":"2019","unstructured":"Frei R, Fournier N, Zeitz J et al. Early initiation of anti-TNF is associated with favourable long-term outcome in Crohn\u2019s disease: 10-year-follow-up data from the Swiss IBD cohort study. J Crohn\u2019s Colitis. 2019;13:1292\u20131301. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjz057.","journal-title":"J Crohn\u2019s Colitis."},{"key":"7714_CR11","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1016\/j.cgh.2018.12.040","volume":"17","author":"DM Faleck","year":"2019","unstructured":"Faleck DM, Winters A, Chablaney S et al. Shorter disease duration is associated with higher rates of response to vedolizumab in patients with Crohn\u2019s disease but not ulcerative colitis. Clin Gastroenterol Hepatol. 2019;17:2497-2505.e1. https:\/\/doi.org\/10.1016\/j.cgh.2018.12.040.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"7714_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2004.060228","author":"E Israeli","year":"2005","unstructured":"Israeli E, Grotto I, Gilburd B et al. Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease. Gut. 2005. https:\/\/doi.org\/10.1136\/gut.2004.060228.","journal-title":"Gut"},{"key":"7714_CR13","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1053\/j.gastro.2020.03.007","volume":"159","author":"J Torres","year":"2020","unstructured":"Torres J, Petralia F, Sato T et al. Serum biomarkers identify patients who will develop inflammatory bowel diseases up to 5 years before diagnosis. Gastroenterology. 2020;159:96\u2013104. https:\/\/doi.org\/10.1053\/j.gastro.2020.03.007.","journal-title":"Gastroenterology."},{"key":"7714_CR14","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.cgh.2016.01.016","volume":"14","author":"P Lochhead","year":"2016","unstructured":"Lochhead P, Khalili H, Ananthakrishnan AN, Richter JM, Chan AT. Association between circulating levels of C-reactive protein and interleukin-6 and risk of inflammatory bowel disease. Clin Gastroenterol Hepatol. 2016;14:818-824.e6. https:\/\/doi.org\/10.1016\/j.cgh.2016.01.016.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"7714_CR15","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1111\/apt.13641","volume":"43","author":"RS Choung","year":"2016","unstructured":"Choung RS, Princen F, Stockfisch TP et al. Serologic microbial associated markers can predict Crohn\u2019s disease behaviour years before disease diagnosis. Aliment Pharmacol Ther. 2016;43:1300\u20131310. https:\/\/doi.org\/10.1111\/apt.13641.","journal-title":"Aliment Pharmacol Ther."},{"key":"7714_CR16","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izaa341","author":"MY Stulman","year":"2021","unstructured":"Stulman MY, Asayag N, Focht G et al. Epidemiology of inflammatory bowel diseases in Israel: a nationwide epi-Israeli IBD research nucleus study. Inflamm Bowel Dis. 2021. https:\/\/doi.org\/10.1093\/ibd\/izaa341.","journal-title":"Inflamm Bowel Dis"},{"key":"7714_CR17","doi-asserted-by":"publisher","first-page":"671","DOI":"10.2147\/CLEP.S151339","volume":"10","author":"MY Friedman","year":"2018","unstructured":"Friedman MY, Leventer-Roberts M, Rosenblum J et al. Development and validation of novel algorithms to identify patients with inflammatory bowel diseases in Israel: an epi-IIRN group study. Clin Epidemiol. 2018;10:671. https:\/\/doi.org\/10.2147\/CLEP.S151339.","journal-title":"Clin Epidemiol."},{"key":"7714_CR18","unstructured":"The Crohn's and Colitis Canada GEM Project. accessed 9 May 2022 http:\/\/www.gemproject.ca\/"},{"key":"7714_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.conctc.2019.100345","author":"CK Porter","year":"2019","unstructured":"Porter CK, Riddle MS, Gutierrez RL et al. Cohort profile of the PRoteomic Evaluation and Discovery in an IBD Cohort of Tri-service Subjects (PREDICTS) study: rationale, organization, design, and baseline characteristics. Contemp Clin Trials Commun. 2019. https:\/\/doi.org\/10.1016\/j.conctc.2019.100345.","journal-title":"Contemp Clin Trials Commun"},{"key":"7714_CR20","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1093\/jamia\/ocv195","volume":"23","author":"Y Kinar","year":"2016","unstructured":"Kinar Y, Kalkstein N, Akiva P et al. Development and validation of a predictive model for detection of colorectal cancer in primary care by analysis of complete blood counts: a binational retrospective study. J Am Med Inform Assoc. 2016;23:879\u2013890. https:\/\/doi.org\/10.1093\/jamia\/ocv195.","journal-title":"J Am Med Inform Assoc."},{"key":"7714_CR21","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1111\/liv.13413","volume":"37","author":"S Saokaew","year":"2017","unstructured":"Saokaew S, Kanchanasuwan S, Apisarnthanarak P et al. Clinical risk scoring for predicting non-alcoholic fatty liver disease in metabolic syndrome patients (NAFLD-MS score). Liver Int. 2017;37:1535\u20131543. https:\/\/doi.org\/10.1111\/liv.13413.","journal-title":"Liver Int."},{"key":"7714_CR22","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1053\/j.gastro.2020.08.005","volume":"159","author":"W Turpin","year":"2020","unstructured":"Turpin W, Lee SH, Raygoza Garay JA et al. Increased intestinal permeability is associated with later development of Crohn\u2019s disease. Gastroenterology. 2020;159:2092-2100.e5. https:\/\/doi.org\/10.1053\/j.gastro.2020.08.005.","journal-title":"Gastroenterology."},{"key":"7714_CR23","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1007\/s00595-019-01893-8","volume":"50","author":"A Er\u0151s","year":"2020","unstructured":"Er\u0151s A, So\u00f3s A, Hegyi P et al. Sarcopenia as an independent predictor of the surgical outcomes of patients with inflammatory bowel disease: a meta-analysis. Surg Today. 2020;50:1138\u20131150. https:\/\/doi.org\/10.1007\/s00595-019-01893-8.","journal-title":"Surg Today."},{"key":"7714_CR24","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/ibd\/izy212","volume":"25","author":"E Ryan","year":"2019","unstructured":"Ryan E, McNicholas D, Creavin B, Kelly ME, Walsh T, Beddy D. Sarcopenia and inflammatory bowel disease: a systematic review. Inflamm Bowel Dis. 2019;25:67\u201373. https:\/\/doi.org\/10.1093\/ibd\/izy212.","journal-title":"Inflamm Bowel Dis."},{"key":"7714_CR25","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1093\/ibd\/izz265","volume":"26","author":"K Vadstrup","year":"2020","unstructured":"Vadstrup K, Alulis S, Borsi A et al. Cost burden of crohn s disease and ulcerative colitis in the 10-year period before diagnosis-a danish register-based study from 2003 2015. Inflamm Bowel Dis. 2020;26:1377\u20131382. https:\/\/doi.org\/10.1093\/ibd\/izz265.","journal-title":"Inflamm Bowel Dis."},{"key":"7714_CR26","doi-asserted-by":"publisher","first-page":"3097","DOI":"10.1007\/s10620-016-4298-8","volume":"61","author":"G Fiorino","year":"2016","unstructured":"Fiorino G, Danese S. Diagnostic delay in Crohn\u2019s disease: time for red flags. Dig Dis Sci. 2016;61:3097\u20133098. https:\/\/doi.org\/10.1007\/s10620-016-4298-8.","journal-title":"Dig Dis Sci."},{"key":"7714_CR27","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1093\/ecco-jcc\/jjx041","volume":"11","author":"L Cantoro","year":"2017","unstructured":"Cantoro L, Di Sabatino A, Papi C et al. The time course of diagnostic delay in inflammatory bowel disease over the last sixty years: an Italian multicentre study. J Crohn\u2019s Colitis. 2017;11:975\u2013980. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjx041.","journal-title":"J Crohn\u2019s Colitis."},{"key":"7714_CR28","doi-asserted-by":"publisher","first-page":"6474","DOI":"10.3748\/wjg.v23.i35.6474","volume":"23","author":"DW Lee","year":"2017","unstructured":"Lee DW, Koo JS, Choe JW et al. Diagnostic delay in inflammatory bowel disease increases the risk of intestinal surgery. World J Gastroenterol. 2017;23:6474\u20136481. https:\/\/doi.org\/10.3748\/wjg.v23.i35.6474.","journal-title":"World J Gastroenterol."},{"key":"7714_CR29","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1097\/MCG.0000000000000421","volume":"50","author":"MD Long","year":"2016","unstructured":"Long MD, Kappelman MD, Martin CF, Chen W, Anton K, Sandler RS. Role of non-steroidal anti-inflammatory drugs in exacerbations of inflammatory bowel disease. J Clin Gastroenterol. 2016;50:152. https:\/\/doi.org\/10.1097\/MCG.0000000000000421.","journal-title":"J Clin Gastroenterol."},{"key":"7714_CR30","doi-asserted-by":"publisher","DOI":"10.1093\/RHEUMATOLOGY\/KEAB678","author":"JW van Straalen","year":"2021","unstructured":"van Straalen JW, Krol RM, Giancane G et al. Increased incidence of inflammatory bowel disease on etanercept in juvenile idiopathic arthritis regardless of concomitant methotrexate use. Rheumatology (Oxford). 2021. https:\/\/doi.org\/10.1093\/RHEUMATOLOGY\/KEAB678.","journal-title":"Rheumatology (Oxford)"},{"key":"7714_CR31","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1007\/S10620-015-4007-Z","volume":"61","author":"A O\u2019Toole","year":"2016","unstructured":"O\u2019Toole A, Lucci M, Korzenik J. inflammatory bowel disease provoked by etanercept: report of 443 possible cases combined from an IBD Referral Center and the FDA. Dig Dis Sci. 2016;61:1772\u20131774. https:\/\/doi.org\/10.1007\/S10620-015-4007-Z.","journal-title":"Dig Dis Sci."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-022-07714-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-022-07714-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-022-07714-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T07:55:10Z","timestamp":1675842910000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-022-07714-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,11]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["7714"],"URL":"https:\/\/doi.org\/10.1007\/s10620-022-07714-2","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,11]]},"assertion":[{"value":"15 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None of the authors have conflicts of interest relevant to this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}